Failure of monoclonal antibodies against CGRP or its receptor does not imply lack of efficacy of other drugs from the same class.

Porta-Etessam, J; González-García, N; Guerrero, Á L; García-Azorín, D

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/87659

Title:	Failure of monoclonal antibodies against CGRP or its receptor does not imply lack of efficacy of other drugs from the same class.
Authors:	Porta-Etessam, J González-García, N Guerrero, Á L García-Azorín, D View more
Mesh:	Antibodies, Monoclonal Calcitonin Gene-Related Peptide Calcitonin Gene-Related Peptide Receptor Antagonists Pharmaceutical Preparations Receptors, Calcitonin Gene-Related Peptide View more
Issue Date:	8-Jul-2021
Citation:	Neurologia (Engl Ed).2021;(36)8:638-640
PMID:	34246579
URI:	https://hdl.handle.net/20.500.12530/87659
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:

The file with the full text of this item is not available due to copyright restrictions or because there is no digital version. Authors can contact the head of the repository of their center to incorporate the corresponding file.

Show full item record

This item is licensed under a Creative Commons License